Delineated as the total market value of all outstanding shares of the company, the current market cap for the AbbVie Inc. is valued at 106413.6. The prevailing figure will allow the investment community to determine the size of AbbVie Inc. in contrast to the sales or total assets figures. As a result, investors will be able to comprehend the basic determinant of asset allocation and all sorts of risk-returns parameters for stocks alongside the stock mutual funds. However, it is a general misunderstanding that a higher share price points towards a larger company where stock price might also misrepresent the definite worth of the organization.
At present, AbbVie Inc. has a PE ratio of 18.04 with a forward P/E of 10.17 *. The PEG holds a value of 1.23 * and the P/S ratio is calculated to be 4.15 *, whilst P/B is stated to be 22.94. AbbVie Inc. grasps an EPS value of 3.65 * displaying an EPS growth of 16.20% * for this year. Accordingly, the company shows a 16.20% EPS growth for the subsequent year and computes the EPS growth for the past five years at 10.90% *. The EPS growth for the next five years accounts to 14.61% *. Sales growth for the last five years strolls at 8.00% *.
The shares outstanding for AbbVie Inc. is levered at 1616 *. The Shares Float shows a value of 1592.31 * and the Insider Ownership illustrates 0.10% *.
AbbVie Inc.’s ROA is currently valued at 9.40% * with a ROI value of 18.00% *. The Current Ratio parades a figure of 1.7 * and the Quick ratio meanders around 1.5 *.
AbbVie Inc. holds a total Debt Equity of 7.95 * with the Long Term Debt/Equity of 7.86 *. The company mirrors a Gross Margin of 77.30% indicating an Operating Profit of 36.60% *. As a result, AbbVie Inc. attained a Profit Margin of 23.20% *.
The weekly performance of AbbVie Inc. is 3.62%, presenting a monthly performance value of 8.23% with the quarterly performance value of 9.22%. AbbVie Inc. has an annual performance rate of 18.43% *.
Volatility on a weekly basis sums at 1.56% * together with the monthly volatility of 1.40% *. AbbVie Inc. has a 20-Day Simple Moving Average 4.90% * and a 200-Day Simple Moving Average of 6.73% *. The 52-Week High confirms a value of -1.53% * with the 52-Week Low of 25.56% *.
Currently, AbbVie Inc. holds a stock price of 65.8 and exhibits a change in price of -0.08%. It has a target price of 69.78 * and started its journey on 1/2/2013 * (IPO Date).
Disclaimer: Outlined statistics and information communicated in the above editorial are merely a work of the authors. They do not ponder or echo the certified policy or position of any business stakeholders, financial specialists, or economic analysts. Specimens laid down on the editorial above are only cases with information collected from various sources. The authority will not be liable for anyone who makes stock portfolio or financial decisions as per the editorial, which is based only on limited and open source
NYSE : ABBV